Neurology Specific Literature Search   
 
[home][thesaurus]
    

Differential
(Click to cross reference)
abdominal protrusion
acetylcholine
acromegaly
advances in neurology
adverse drug reaction
affective disorders
agitation
akathisia
algorithm
alpha methyldopa hydrazine
Alzheimer's disease
amantadine
amitriptyline
amphetamines
amphetamines, dyskinesia associated with
amygdala
anesthesia, general
anticholinergic drugs
anticholinergic drugs, side effects of
antidepressant
antihistamines
anxiety
apomorphine
aprazolam
arrhythmia, cardiac
aspartate aminotransferase
asterixis
atypical
autonomic dysfunction
axillary nerve
ballismus, bilateral
behavioral disorder
benzodiazepine
bladder dysfunction
bradykinesia
bromocriptine
Brueghel's syndrome
burning paresthesia
buspirone
carbidopa
CAT scan, emission
catechol-o-methyltransferase inhibitor
chest pain
chorea
clonazepam
clozapine
complications
confusion
controversies in neurology
Coombs test, positive
cough
delirium
delusion
dementia
deprenyl
depression
desipramine
diabetes mellitus
diarrhea
dopamine
dopamine agonist
drug abuse
drug addiction
drug holiday
drug induced neurologic disorders
drug interactions
drug withdrawal
dyskinesia
dyskinesia, buccal lingual facial
dyskinesia, drug induced
dyspnea
dystonia
dystonia, treatment of
efficacy
electroencephalogram
electroencephalogram, abnormalities of
electroencephalogram, periodic complexes
electroencephalogram, triphasic delta waves
encephalopathy
entacapone
enzyme inhibition
enzyme, serum
epidemiology of neurology
excitotoxin
genetic neurologic disorders
globus pallidus, stimulation
groaning
hallucination
hallucination, visual
haloperidol
hemiballismus
hemidystonia
hunger
hyperthermia
iatrogenic neurologic disorders
imipramine
infusion pump
intellectual deficit
isoniazid
L-dopa
L-dopa, controlled release
L-dopa, delayed treatment in Parkinsonism
L-dopa, drug interactions with and side effects of
L-dopa, enteral infusion, continuous
L-dopa, plasma concentration
L-dopa, potentiators of
Lewy body
Lewy body disease, diffuse
livedo reticularis
liver function enzymes
locus ceruleus, lesion of
lorazepam
manic-depressive
melanoma, malignant
memory
memory, impairment of
mental status, abnormal
mitochondrial disease
monoamine oxidase inhibitors
mortality
movement disorder
movement disorder, drug induced
movement disorder, extrapyramidal
movement disorder, treatment of
MRI
myoclonic jerks
myoclonus
myoclonus, sleep
nausea and vomiting
neuroendocrinology
neuroleptic
neuroleptic malignant syndrome
neuroleptic, atypical
neurologic complications of, surgery
neurologic signs
neurologist
neuronal degeneration
neuropathology
nigrostriatal pathway
nortriptyline
olanzapine
ondansetron
oral contraceptives
oral contraceptives, choreiform movements with
orthostatic hypotension
pain
pallidotomy
panic attacks
papaverine
paranoia
paresthesias
Parkinson disease
Parkinson disease, complications, late
Parkinson disease, dementia with
Parkinson disease, diagnosis
Parkinson disease, differential diagnosis of
Parkinson disease, drug holiday
Parkinson disease, dystonia with
Parkinson disease, early symptoms
Parkinson disease, fluctuations in
Parkinson disease, nonmotor problems of
Parkinson disease, on-off phenomena in
Parkinson disease, pathogenesis of
Parkinson disease, postencephalitic
Parkinson disease, sensory symptoms in
Parkinson disease, surgical treatment of
Parkinson disease, treatment of
Parkinson disease, young onset
Parkinsonism plus syndrome
Parkinsonism syndrome
parsidol
patient information and support
pergolide
phenothiazine
phenothiazine, dyskinesia associated with
phobias
pramipexole
procyclidine
progressive supranuclear palsy
psychiatric disorder
psychiatric problems in neurologic disorders
psychosis
psychotic behavior
pyridoxine
quetiapine
raphe nuclei
reserpine and reserpine like drugs
reserpine treatment in movement disorder
respirations in CNS disease
respiratory dyskinesias
review article
rigidity
ritalin
ropinirole
selective serotonin reuptake inhibitors
serotonin antagonist
serum alanine aminotransferase
sinemet
single photon emission computed tomography
sleep pathology and physiology
start hesitation
stimulation, deep brain
substantia nigra
subthalamic nucleus
subthalamic nucleus deep brain stimulation
tardive dyskinesia
tolcapone
tonic foot response
torticollis
trazodone
treatment of neurologic disorder
tremor
tremor, thalamic stimulation for suppression of
tricyclic antidepressant
trigeminal neuralgia
vitamin, multiple
vocalizations
Showing articles 50 to 100 of 982 << Previous Next >>

Fatal Hyperpyrexia After Withdrawal of Levodopa
Neurol 34:249-251, Sechi,G.P.,et al, 1984

Meige's Syndrome During Long-term Dopaminergic Therapy in Parkinson's Disease
Arch Neurol 39:451-452, Weiner,W.J.,et al, 1982

Drug-induced Asterixis in Parkinson Disease
Neurol 32:553-555, Glantz,R.,et al, 1982

Complications of Chronic Levodopa Therapy; Long-term Efficacy of Drug Holiday
Neurol 31:473-476, Koller,W.C.,et al, 1981

Sinemet & the Treatment of Parkinsonism
Ann Int Med 94:364-370, Boshes,B., 1981

Parkinsonism With`On-Off'Phenomena-Intravenous Treatment With Levodopa After Major Abdominal Surgery
Arch Neurol 36:32-34, Rosin,A.J.,et al, 1979

Analysis of the Clinical Problems in Parkinsonism & the Complications of Long-term Levodopa Therapy
Neurol 29:1253-1260, Lesser,R.P.,et al, 1979

Dementia in Parkinson Disease
Ann Neurol 6:355-359, Lieberman,A.,et al, 1979

Early-Morning Dystonia-A Late Side Effect of Long-Term Levodopa Therapy
Arch Neurol 36:308-310, Melamed,E., 1979

The L-Dopa On-Off Effect in Parkinson Disease:Treat. by Trans. Drug Withdrawal & Dopamine Receptor Resens
Ann Neurol 4:573-575, Direnfeld,L.,et al, 1978

Respiratory Dyskinesias:Extrapyramidal Dysfunction & Dyspnea
Ann Int Med 88:327, Weiner,W.J.,et al, 1978

Considerations in the Management of Parkinsonism
Neurol 28:5, Fahn,S.,et al, 1978

Onset & End-of-dose Levodopa-induced Dyskinesias
Arch Neurol 35:261, Lhermitte,F.,et al, 1978

Drug Therapy of Parkinsonism
NEJM 295:814, Bianchine,J.R., 1976

Drugs that Reduce Efficacy of Levodopa
(Letter) , NEJM 295:153876., Hausner,R., 1976

Levodopa-Induced Myoclonus
Arch Neurol 32:331-334, Klawans,H.L., 1975

Prolonged Levodopa Therapy
BMJ 383, Feb 1973., , 1973

Start Hesitation-A Side Effect of Long-Term Levodopa Therapy
NEJM 288:1113, Ambani,L.,et al, 1973

Occurence of Positive Coombs Test in Patients Treated with Levodopa
NEJM 286:1401, Joseph,C., 1972

Methyldopahydrazine as an Adjunct to L-Dopa Therapy in Parkinsonism
Neurol 22:384, Chase,T.,et al, 1972

Metabolic Responses to Acute & Chronic L-Dopa Administration in Patients with Parkinsonism
NEJM 287:729, Sirtori,C.,et al, 1972

Drug Therapy of Parkinsonism
NEJM 287:20, Yahr,M.,et al, 1972

Modern Treatment of Parkinson's Disease
Excerpta Medica 2:1972 Aug., , 1972

Modern Treatment of Parkinson's Disease
Excerpta Medica, 2:1971 Jun-Jul., , 1971

Drug-Induced Movement Disorders
Postgrad Med 180, 1971, Sept., North,R., 1971

Manic Response to Levodopa Therapy
NEJM 285:788, Ryback,R.,et al, 1971

Monoamine Oxidase Inhibitor & L-Dopa
BMJ 3:388, Hunter,H.R.,et al, 1970

Juvenile-Onset Dopa-Responsive Dystonia-Until It Isnt
Neurol 104:e213436, Paredes,N.C.,et al, 2025

Parkinsons Disease
NEJM 391:442-452, Tanner,C.M. & Ostrem,J.L., 2024

A Young Woman With Hypertonia, Severe Scoliosis, and Encephalopathy
JAMA Neurol 81:83-84, Hua,L.,et al, 2024

A 6-Year-Old Girl with Progressive Toe Walking
Neurol 98:e769-e773, Libdeh, A.A. & Ibrahim, A., 2022

Diagnosis and Treatment of Parkinson Disease
JAMA 323:548-560, Armstrong, M.J. & Okun, M.S., 2020

Vitamin B6 Deficiency Presenting with New-Onset Epilepsy and Status Epilepticus in a Patient with Parkinson Disease
Neurol 94:e2605-e2607, Modica, J.S.,et al, 2020

When to Start Levodopa Therapy for Parkinsons Disease
NEJM 380:389-390, Bressman, S. & Saunders-Pullman, R., 2019

Safety and Efficacy of Focused Ultrasound Thalamotomy for Patients with Medication-Refractory, Tremor-Dominant Parkinson Disease
JAMA Neurol 74:1412-1418, Bond, A.E.,et al, 2017

A 56-year-old Man with Cognitive Impairment and Difficulty Tying his Necktie
Neurol 85:e116-e122, Baker, J.M.,et al, 2015

Parkinsons Disease Beyond 20 Years
JNNP 86:849-855, Cilia, R.,et al, 2015

Long-Term Effectivenss of Dopamine Agonists and Monoamine Oxidase B Inhibitors Compared with Levodopa as Initial Treatment for Parkinsons Disease (PD MED): A Large, Open-Label, Pragmatic Randomised Trial
Lancet 383: Doi: 10.1016/S0140-6736, PD MED Collaborative Group, 2014

Disturbances of Cerebrospinal Fluid, Including Hydrocephalus, Pseudotumor Cerebri, and Low-Pressure Syndromes, Parkinsonism and Midbrain Syndromes with Hydrocephalus and Shunting
Adams & Victors Principles of Neurology, Chp 30, pg 627, Ropper, A.H.,et al, 2014

Degenerative Diseases of the Nervous System, Parkinson Disease
Adams & Victors Principles of Neurology, Chp 39, pg 1082, Ropper, A.H.,et al, 2014

Criteria for the Diagnosis of Corticobasal Degeneration
Neurol 80:496-503, Armstrong, M.J.,et al, 2013

Parkin Disease
JAMA Neurol 70:571-579, Doherty, K.,et al, 2013

Deep-Brain Stimulation for Parkinsons Disease
NEJM 367:1529-1538, Okon, M.S., 2012

Dopa-Responsive Dystonia Revisited
Arch Neurol 69:1558-1562, Tadic, V.,et al, 2012

Deep Brain Stimulation for Parkinson Disease: An Expert Consensus and Review of Key Issues
Arch Neurol 68:165-171, Bronstein,J.M.,et al, 2011

Clinicopath Conf, Rapid-Onset-Dystonia-Parkinsonism Due to a Mutation in the ATP1A3 Gene
NEJM 362:2213-2219, Case 17-2010, 2010

A Meta-Regression of the Long-Term Effects of Deep Brain Stimulation on Balance and Gait in PD
Neurol 75:1292-1299, St. George,R.J.,et al, 2010

Othello Syndrome in Parkinson Disease Patients Without Dementia
The Neurologist 15:34-36, Cannas,A.,et al, 2009

Parkinsons Disease
Lancet 373:2055-2066, Lees,A.J.,et al, 2009

Progressive Supranuclear Palsy: A Current Review
The Neurologist 14:79-88, Lubarsky,M. &Juncos,J.L., 2008



Showing articles 50 to 100 of 982 << Previous Next >>